BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2731568)

  • 1. Myasthenia gravis in the county of Viborg, Denmark.
    Sørensen TT; Holm EB
    Eur Neurol; 1989; 29(3):177-9. PubMed ID: 2731568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.
    Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B
    Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of myasthenia gravis in the province of Trento (northern Italy).
    Ferrari G; Lovaste MG
    Neuroepidemiology; 1992; 11(3):135-42. PubMed ID: 1407249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
    Niks EH; Kuks JB; Verschuuren JJ
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Some epidemiological aspects of myasthenia gravis in Cuba].
    Cisneros AD; Luis RS; León R; Carrera PL
    Rev Neurol; 1996 Apr; 24(128):435-9. PubMed ID: 8721922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.
    Santos E; Coutinho E; Moreira I; Silva AM; Lopes D; Costa H; Silveira F; Nadais G; Morais H; Martins J; Branco MC; Veiga A; Silva RS; Ferreira A; Sousa F; Freijo M; Matos I; André R; Negrão L; Fraga C; Santos M; Sampaio M; Lopes C; Leite MI; Gonçalves G
    Muscle Nerve; 2016 Sep; 54(3):413-21. PubMed ID: 26851892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis: a higher than expected incidence in the elderly.
    Aragonès JM; Bolíbar I; Bonfill X; Bufill E; Mummany A; Alonso F; Illa I
    Neurology; 2003 Mar; 60(6):1024-6. PubMed ID: 12654975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis incidence in a general North Atlantic isolated population.
    Joensen P
    Acta Neurol Scand; 2014 Oct; 130(4):222-8. PubMed ID: 24981565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009.
    Pedersen EG; Hallas J; Hansen K; Jensen PE; Gaist D
    Eur J Neurol; 2013 Feb; 20(2):309-14. PubMed ID: 22882327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of myasthenia gravis in the Catalan county of Osona.
    Aragonès JM; Altimiras J; Roura P; Alonso F; Bufill E; Munmany A; Alfonso S; Illa I
    Neurologia; 2017; 32(1):1-5. PubMed ID: 25449965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
    Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
    Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.
    Robertson NP; Deans J; Compston DA
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):492-6. PubMed ID: 9771771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national epidemiological study of Myasthenia Gravis in Australia.
    Gattellari M; Goumas C; Worthington JM
    Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population based epidemiological study on myasthenia gravis in Estonia.
    Oöpik M; Kaasik AE; Jakobsen J
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
    Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
    Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of seropositive myasthenia gravis in Greece.
    Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of myasthenia gravis in Finland.
    Hokkanen E
    J Neurol Sci; 1969; 9(3):463-78. PubMed ID: 5367040
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of myasthenia gravis in Ontario, Canada.
    Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
    Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of myasthenia gravis.
    Kurtzke JF
    Adv Neurol; 1978; 19():545-66. PubMed ID: 369334
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
    Somnier FE
    Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.